3601 - 3610 of 6310 Results
Title
Year
-
OPENTitle: Parkinson-like wild-type superoxide dismutase 1 pathology induces nigral dopamine neuron degeneration in a novel murine modelJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 149Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-025-02859-6Best OA location URL: https://doi.org/10.1007/s00401-025-02859-6Citation Count: 1
-
OPENTitle: Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson’s DiseaseJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 18Issue #: 5Start Page: 2109End Page: 2120Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.8b00982Citation Count: 65
-
OPENTitle: A Novel Lead Design for Modulation and Sensing of Deep Brain StructuresJournal Name: IEEE Transactions on Biomedical EngineeringPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 63Issue #: 1Start Page: 148End Page: 157Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/tbme.2015.2492921Best OA location URL: http://doi.org/10.1109/TBME.2015.2492921Citation Count: 38
-
OPENTitle: Role of data measurement characteristics in the accurate detection of Parkinson’s disease symptoms using wearable sensorsJournal Name: Journal of NeuroEngineering and RehabilitationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12984-020-00684-4Best OA location URL: https://jneuroengrehab.biomedcentral.com/track/pdf/10.1186/s12984-020-00684-4Citation Count: 81
- Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial2018OPENTitle: Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 51End Page: 56Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.10.005Best OA location URL: http://www.prd-journal.com/article/S1353802018304310/pdfCitation Count: 17
-
OPENTitle: PP1 Phosphatase Complexes: Undruggable No LongerJournal Name: CellPublisher: Elsevier BVVol: 174Issue #: 5Start Page: 1049End Page: 1051Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oa, elsevier-specific: oa user licenseDOI - Digital Object Identifier: 10.1016/j.cell.2018.08.007Best OA location URL: http://www.cell.com/article/S0092867418310237/pdfCitation Count: 11
-
OPENTitle: Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutationsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 33Issue #: 4Start Page: 814End Page: 823Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2010.05.009Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2010.05.009Citation Count: 215
- CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease2021OPENTitle: CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 7Start Page: 2047End Page: 2059Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awab103Best OA location URL: https://academic.oup.com/brain/article-pdf/144/7/2047/39769283/awab103.pdfCitation Count: 245
-
OPENTitle: Stiripentol for the treatment of super-refractory status epilepticusJournal Name: Acta Neurologica ScandinavicaPublisher: WileyVol: 132Issue #: 6Start Page: 435End Page: 439Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ane.12403Best OA location URL: https://doi.org/10.1111/ane.12403Citation Count: 42
-
OPENTitle: β2‐adrenoreceptor medications and risk of Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 84Issue #: 5Start Page: 683End Page: 693Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25341Citation Count: 72